AU510124B2 - Radionuclide carries - Google Patents

Radionuclide carries

Info

Publication number
AU510124B2
AU510124B2 AU15478/76A AU1547876A AU510124B2 AU 510124 B2 AU510124 B2 AU 510124B2 AU 15478/76 A AU15478/76 A AU 15478/76A AU 1547876 A AU1547876 A AU 1547876A AU 510124 B2 AU510124 B2 AU 510124B2
Authority
AU
Australia
Prior art keywords
radionuclide
carries
radionuclide carries
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU15478/76A
Other versions
AU1547876A (en
Inventor
F. A. Kretschmar H. C. and Tole A. J Hartman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to AU15478/76A priority Critical patent/AU510124B2/en
Publication of AU1547876A publication Critical patent/AU1547876A/en
Application granted granted Critical
Publication of AU510124B2 publication Critical patent/AU510124B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
AU15478/76A 1976-07-01 1976-07-01 Radionuclide carries Expired AU510124B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU15478/76A AU510124B2 (en) 1976-07-01 1976-07-01 Radionuclide carries

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU15478/76A AU510124B2 (en) 1976-07-01 1976-07-01 Radionuclide carries

Publications (2)

Publication Number Publication Date
AU1547876A AU1547876A (en) 1978-01-05
AU510124B2 true AU510124B2 (en) 1980-06-12

Family

ID=3705541

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15478/76A Expired AU510124B2 (en) 1976-07-01 1976-07-01 Radionuclide carries

Country Status (1)

Country Link
AU (1) AU510124B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0207557A2 (en) * 1985-06-28 1987-01-07 The Procter & Gamble Company Diphosphonate-derivatized macromolecules

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0207557A2 (en) * 1985-06-28 1987-01-07 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
EP0207557A3 (en) * 1985-06-28 1987-09-09 The Procter & Gamble Company Diphosphonate-derivatized macromolecules

Also Published As

Publication number Publication date
AU1547876A (en) 1978-01-05

Similar Documents

Publication Publication Date Title
AU2107377A (en) Phathalanes
AU2329877A (en) Hentriakontapeptides
AU2350877A (en) Arylmalonamido-1-oxadethiacephalosporins
AU2289777A (en) E-2-propynyl-benzylamines
AU2268977A (en) 3-Phenyl-2-Oxazolidinones
AU2676477A (en) Surf-Ski
AU2696477A (en) Pipejoint
AU2401277A (en) Trans-hexahydro-pyrido-indoles
AU2838577A (en) Perhydro-aza-heterocycles
AU2372777A (en) Amidinoureas
AU2694177A (en) 7-b-oxyiminoacylcephalosporins
AU2464877A (en) Aminopiperidines
AU2356677A (en) Coccidiocide
AU2921577A (en) Methanisation
AU2537677A (en) Aryltrifluoroethylamines
AU2765177A (en) N-sulphenylated oxime-carbamates
AU2915477A (en) Corticods
AU2543477A (en) 1-ARYLOXY-2-HYDROXY-3-AMINOPROPANeS
AU2370677A (en) Amidinopenicillanoyloxyalkyl amoxycillinates
AU2228277A (en) 3-deoxyanthocyanidins
AU2421077A (en) Benzoylethers
AU2922377A (en) Airsifters
AU2912577A (en) 1-amino-2-hydroxy-3-heterocycloxy-propanes
AU2428577A (en) Bis-pencillanoyloxy-alkanes
AU2556877A (en) Substicuted 2-vinyl-chromones